Home › Funds › Soleus Capital Management, L.P. › SUPN

Soleus Capital Management, L.P. position in SUPN

SUPERNUS PHARMACEUTICALS · Health Care

Soleus Capital Management, L.P. reported holding 520,000 shares of SUPN (SUPERNUS PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$24.2M, representing 0.83% of its reported portfolio and ranking #34 among its reported holdings. Soleus Capital Management, L.P. first reported this position in Q2 2026.

Latest position (Q2 2026)520.00K sh
Reported value held$24.19M
Portfolio Weight0.83%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Soleus Capital Management, L.P.'s SUPN position evolved

Soleus Capital Management, L.P. first disclosed a stake in SUPN in Q2 2026 at 520,000 shares (US$24.2M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 520.00K $24.19M New

About SUPN and 13F data

SUPN (SUPERNUS PHARMACEUTICALS) is a Health Care company. 34 other funds we track also report a position in SUPN — the largest reported positions include MILLENNIUM MANAGEMENT LLC (US$179.2M), ARMISTICE CAPITAL, LLC (US$123.1M), Sofinnova Investments, Inc. (US$48.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SUPN

All SUPN fund holders →

FAQ

How long has Soleus Capital Management, L.P. held SUPN?

Soleus Capital Management, L.P. has disclosed SUPN holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Soleus Capital Management, L.P.'s current position in SUPN?

As of Q2 2026, Soleus Capital Management, L.P. holds 520.00K shares of SUPN (SUPERNUS PHARMACEUTICALS), valued at $24.19M, representing 0.83% of its reported portfolio and ranking #34.

Has Soleus Capital Management, L.P. been buying or selling SUPN?

In the latest 13F filing (Q2 2026), Soleus Capital Management, L.P. newly opened its position in SUPN.

Which other funds hold SUPN?

Other major institutional holders of SUPN include MILLENNIUM MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, Sofinnova Investments, Inc., among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.